Xenetic Biosciences Earnings
NASDAQ: XBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.40-0.14 (-9.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Xenetic Biosciences earnings summary
In its most recent report on Nov 12, 2026 (Sep/2026), XBIO posted EPS of $-0.72.
Summary generated from market data by MetaCap's automated system. Methodology
XBIO earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2026 | — | $-0.72 | — | -15.7% |
| Nov 11, 2026 | — | $-0.33 | — | -15.7% |
| Aug 6, 2026 | — | $-0.41 | — | — |
| May 12, 2026 | — | $-0.20 | — | — |
| Mar 12, 2026 | — | $-0.21 | — | — |
| Nov 12, 2025 | — | $-0.33 | — | — |
| Aug 12, 2025 | — | $-0.45 | — | — |
| May 13, 2025 | — | $-0.59 | — | — |
| Mar 18, 2025 | — | $-0.68 | — | — |
| Nov 12, 2024 | — | $-0.28 | — | — |
| Aug 13, 2024 | — | $-0.83 | — | — |
| May 9, 2024 | — | $-0.78 | — | — |
| Mar 21, 2024 | — | $-0.77 | — | — |
| Nov 9, 2023 | — | $-0.69 | — | — |
| Aug 10, 2023 | — | $-0.69 | — | — |
| May 11, 2023 | — | $-0.56 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.